PRVA Valuation
Privia Health Group Inc
$
21.145
- Overview
- Forecast
- Valuation
- Earnings
PRVA Relative Valuation
PRVA's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, PRVA is overvalued; if below, it's undervalued.
Historical Valuation
Privia Health Group Inc (PRVA) is now in the Undervalued zone, suggesting that its current forward PS ratio of 0.00 is considered Undervalued compared with the five-year average of 43.83. The fair price of Privia Health Group Inc (PRVA) is between +Inf to +Inf according to relative valuation methord. Compared to the current price of 21.14 USD , Privia Health Group Inc is Undervalued By Fair.
Relative Value
Fair Zone
+Inf-+Inf
Current Price：21.14
Fair
Undervalued
78.08
PE
1Y
3Y
5Y
Trailing
Forward
17.98
EV/EBITDA
Privia Health Group Inc. (PRVA) has a current EV/EBITDA of 17.98. The 5-year average EV/EBITDA is 38.36. The thresholds are as follows: Strongly Undervalued below -3.92, Undervalued between -3.92 and 17.22, Fairly Valued between 59.50 and 17.22, Overvalued between 59.50 and 80.64, and Strongly Overvalued above 80.64. The current Forward EV/EBITDA of 17.98 falls within the Historic Trend Line -Fairly Valued range.
57.84
EV/EBIT
Privia Health Group Inc. (PRVA) has a current EV/EBIT of 57.84. The 5-year average EV/EBIT is 1182.63. The thresholds are as follows: Strongly Undervalued below -7799.17, Undervalued between -7799.17 and -3308.27, Fairly Valued between 5673.52 and -3308.27, Overvalued between 5673.52 and 10164.42, and Strongly Overvalued above 10164.42. The current Forward EV/EBIT of 57.84 falls within the Historic Trend Line -Fairly Valued range.
1.19
PS
Privia Health Group Inc. (PRVA) has a current PS of 1.19. The 5-year average PS is 2.00. The thresholds are as follows: Strongly Undervalued below 0.19, Undervalued between 0.19 and 1.10, Fairly Valued between 2.90 and 1.10, Overvalued between 2.90 and 3.81, and Strongly Overvalued above 3.81. The current Forward PS of 1.19 falls within the Historic Trend Line -Fairly Valued range.
24.47
P/OCF
Privia Health Group Inc. (PRVA) has a current P/OCF of 24.47. The 5-year average P/OCF is 46.79. The thresholds are as follows: Strongly Undervalued below 5.48, Undervalued between 5.48 and 26.14, Fairly Valued between 67.45 and 26.14, Overvalued between 67.45 and 88.10, and Strongly Overvalued above 88.10. The current Forward P/OCF of 24.47 falls within the Undervalued range.
24.75
P/FCF
Privia Health Group Inc. (PRVA) has a current P/FCF of 24.75. The 5-year average P/FCF is 46.78. The thresholds are as follows: Strongly Undervalued below 5.70, Undervalued between 5.70 and 26.24, Fairly Valued between 67.33 and 26.24, Overvalued between 67.33 and 87.87, and Strongly Overvalued above 87.87. The current Forward P/FCF of 24.75 falls within the Undervalued range.
Privia Health Group Inc (PRVA) has a current Price-to-Book (P/B) ratio of 3.69. Compared to its 3-year average P/B ratio of 5.06 , the current P/B ratio is approximately -27.03% higher. Relative to its 5-year average P/B ratio of 6.36, the current P/B ratio is about -41.96% higher. Privia Health Group Inc (PRVA) has a Forward Free Cash Flow (FCF) yield of approximately 0.00%. Compared to its 3-year average FCF yield of 2.54%, the current FCF yield is approximately -100.00% lower. Relative to its 5-year average FCF yield of 2.29% , the current FCF yield is about -100.00% lower.
3.69
P/B
Median3y
5.06
Median5y
6.36
3.69
FCF Yield
Median3y
2.54
Median5y
2.29
Competitors Valuation Multiple
The average P/S ratio for PRVA's competitors is 0.56, providing a benchmark for relative valuation. Privia Health Group Inc Corp (PRVA) exhibits a P/S ratio of , which is -100.00% above the industry average. Given its robust revenue growth of 23.40%, this premium appears sustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Performance Decomposition
1Y
3Y
5Y
Market capitalization of PRVA increased by 2.83% over the past 1 year. The primary factor behind the change was an increase in Revenue Growth from 422.33M to 521.15M.
The secondary factor is the P/E Change, contributed 22.16%to the performance.
Overall, the performance of PRVA in the past 1 year is driven by Revenue Growth. Which is more sustainable.
People Also Watch
AESI
Atlas Energy Solutions Inc
11.940
USD
+0.93%
LIVN
LivaNova PLC
51.950
USD
+2.59%
JBLU
JetBlue Airways Corp
5.045
USD
+5.32%
MCY
Mercury General Corp
74.970
USD
+1.32%
GRBK
Green Brick Partners Inc
70.620
USD
+5.20%
EQX
Equinox Gold Corp
6.830
USD
+0.29%
KYMR
Kymera Therapeutics Inc
41.020
USD
+2.88%
STNG
Scorpio Tankers Inc
45.250
USD
+0.73%
CWT
California Water Service Group
47.150
USD
+0.88%
FCPT
Four Corners Property Trust Inc
25.470
USD
+0.32%
FAQ
Is Privia Health Group Inc (PRVA) currently overvalued or undervalued?
Privia Health Group Inc (PRVA) is now in the Undervalued zone, suggesting that its current forward PS ratio of 0.00 is considered Undervalued compared with the five-year average of 43.83. The fair price of Privia Health Group Inc (PRVA) is between +Inf to +Inf according to relative valuation methord. Compared to the current price of 21.14 USD , Privia Health Group Inc is Undervalued By Fair .
What is Privia Health Group Inc (PRVA) fair value?
How does PRVA's valuation metrics compare to the industry average?
What is the current P/B ratio for Privia Health Group Inc (PRVA) as of Aug 13 2025?
What is the current FCF Yield for Privia Health Group Inc (PRVA) as of Aug 13 2025?
What is the current Forward P/E ratio for Privia Health Group Inc (PRVA) as of Aug 13 2025?